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ABSTRACT
We analyzed VEGF expression in regenerating liver (after partial 
hepatectomy) of tumor-bearing adult and young mice, throughout 
one complete circadian cycle. The animals were sacrificed every 4 h, 
from 26 to 46  h post-hepatectomy. Liver samples were processed 
for immunohistochemistry. The results showed circadian variation 
of VEGF expression in hepatectomized mice (control group) and 
hepatectomized-tumor-bearing mice. The maximum value of VEGF 
expression was found at 16:00/30 h of day/hour post-hepatectomy 
(HD/HPH) in tumor-bearing young mice, and at 20:00/34 HD/HPH in 
the controls. In adult mice the maximum values of VEGF expression 
were at 16:00/30 HD/HPH in tumor-bearing mice, and at 08:00/46 HD/
HPH in the controls. Young tumor-bearing mice showed significantly 
higher mean values than the controls. In conclusion, the presence of 
the tumor in the animals induces modifications in the intensity and 
the temporal distribution of the circadian curves of VEGF expression.
Introduction
In numerous cell populations, in response to specific conditions associated with different 
stages of the organism’s life span, cell cycle length may vary. It is regulated by growth factors 
and other signaling molecules that stimulate or inhibit cellular proliferation (García et al. 
2001). In mammals, circadian rhythms are generated by a central clock in the suprachiasmatic 
nucleus located in the hypothalamus that constantly synchronize with environmental cues 
via circadian input pathways and controls the peripheral clocks through circadian output 
pathways (Reppert and Weaver 2002; Buijs et al. 2006).
The liver is an organ with a high regenerative capacity. Partial hepatectomy (PH) alters 
the serum concentrations of substances involved in cellular proliferation, leading to the 
compensatory liver hyperplasia (Fausto et al. 2012). Liver regeneration after PH offers a 
unique and robust model to study initiation, progression and termination of tissue growth 
in vivo. A major goal is to understand this process in humans in order to apply this knowledge 
in regenerative medicine, or to oppose deregulated proliferation and growth in tumorigen-
esis (Kurinna and Barton 2011).
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A particularly useful model to study liver regeneration in mice and rats involves removal 
of the large and median lobes of the liver, which comprise approximately two-thirds of the 
organ. As a consequence, quiescent and highly differentiated liver cells of the remaining 
liver proliferate to restore the original liver mass within a few days (approximately 10 days 
in rodents). Hepatocytes are the first to enter in the cell cycle and undergo one to two rounds 
of cell division within 2–3 days (Böhm et al. 2010). Partial hepatectomy is a widely used 
method for liver regeneration studies because it is not accompanied by massive inflamma-
tion or necrosis processes.
In liver regeneration, the development of new capillary blood vessels by sprouting from 
existent microvessels is a fundamental requirement for cellular proliferation (Ribatti and 
Crivellato 2012). This complicated process, defined as angiogenesis, is promoted by VEGF 
(vascular endothelial growth factor), which is the most potent and specific growth factor for 
both angiogenesis and vasculogenesis (Shibuya 1995). The mRNA of what is expressed after 
PH in hepatocytes and non-parenchymal cells suggests that VEGF plays a significant role in 
liver regeneration (Mochida et al. 1996; Furnus et al. 2003). Alterations in angiogenesis can 
include reduced expression of VEGF in the injured or diseased aged animals relative to young 
controls (Sadoun and Reed 2003). So, in this study we used young and adult mice to compare 
the possible differences in VEGF expression due to age along a circadian period (Schmitt 
and Cantley 2008; Schmucker and Sanchez 2011). On the other hand, it has been demon-
strated that tumor bearing in adult mice could modify the intensity and temporal distribution 
of VEGF expression (Andrini et al. 2010).
In this work, we used a hepatocellular carcinoma, which was characterized in our labo-
ratory from the morphological point of view (following the classification by Reuber 1966). 
It is an encapsulated tumor, of firm consistency, with large areas of necrosis and hemorrhages. 
This rapidly growing undifferentiated hepatocellular carcinoma is maintained by subcuta-
neous serial transplant in male mice.
For all the above mentioned, the aim of this study was to analyze the magnitude and 
temporal distribution of VEGF expression in the regeneration liver (after PH) of adult and 
young male mice bearing ES2 hepatocellular carcinoma, throughout one complete circadian 
cycle.
Materials and methods
Animals
For these experiments, we used adult (90 days old) and young male (28 days old) C3H/S 
strain mice. They were subjected to the following standardization conditions: water and 
food available ad libitum, ambient temperature maintained at 22 ± 2 °C, alternating light 
and dark periods restricted to 12 h each with illumination by fluorescent lamps beginning 
at 06:00 h (Echave Llanos et al. 1963).
The conditions concerning animal management fully respected the policy and mandates 
of the Guide for the Care and Use of Laboratory Animal Research of the National Research 
Council.
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Tumor-bearing animals
After an appropriate period of synchronization (between 7 days in young mice and 15 days 
in adult mice), about 70 mg of the C3H/S histocompatible ES2a hepatocellular carcinoma 
was grafted into the subcutaneous tissue of each animal’s flank. The graft-bearing animals 
were subsequently divided into lots of five to eight mice each; then, they were housed under 
standardization conditions before the lots were separated into the experimental-protocol 
groups.
Tissue samples
The animals were sacrificed at 12:00/26, 16:00/30, 20:00/34, 00:00/38, 04:00/42, and 08:00/46 
HD/HPH. Samples of liver were removed promptly, fixed in 10% buffered formalin for 24 h, 
processed routinely and embedded in paraffin. Five-micrometer sections were cut, placed 
on positive-charge slides and dried in an oven at 58 °C overnight.
Determination of VEGF expression
Sections were deparaffinized in xylene and rehydrated. Slides were washed in Tris buffer 
saline (TBS) and irradiated in a household microwave oven (750 W), in buffer citrate for 
20 min, then washed in TBS and incubated with primary antibody (VEGF-A clone C-1, Santa 
Cruz Biotechnology, California, USA) at 1/80 dilution in a humid chamber overnight, at room 
temperature. As detection system, Envision™ (DAKO, Carpinteria, California, USA) was used. 
The reaction was developed using 3′3-diaminobenzidine (DAB, DAKO) in TBS with 0.03% 
H2O2. The sections were slightly counterstained with Mayer’s hematoxylin and mounted. 
Negative controls were run in parallel, omitting primary antibody.
The positive control was a section of liver that had previously shown to have a high VEGF 
content, by immunohistochemistry. VEGF staining was seen in the cytoplasm of tumor cells.
Experimental groups
The animals were divided into two experimental groups: group I (young mice): (a) hepatec-
tomized (controls) and (b) hepatectomized and tumor-bearing animals and group II (adult 
mice): (a) hepatectomized (controls) and (b) hepatectomized and tumor-bearing animals. 
Each group (young and adult mice) were divided into 6 (six) lots of about 5–6 mice each. 
Then, they were housed for further 1 or 2 weeks (group I and II, respectively) under stand-
ardization conditions. All the animals were subjected to a PH at 10:00 h. The animals were 
sacrificed every 4 h starting at 12:00/26 h of day/hours post-hepatectomy (HD/HPH) until 
08:00/46 HD/HPH.
Statistical analysis
The liver sections were examined microscopically under an oil-immersion objective (at 
1500×) to score the total number of labeled cells within a minimum of 3000 cells. The expres-
sion of VEGF was assessed according to the percentage of immunoreactive cells in a total of 
1000 cells (quantitative analysis). The statistical analysis of VEGF expression was performed 
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using Student’s t-test, Anova and Tukey as a post-comparison test. The results were expressed 
as a percentage of labeled cells.
Results
As we can see in the Tables 1 and 2, our results show circadian variation in VEGF expression 
between both experimental groups. In group I we can observe that the mean values of the 
tumor-bearing animals were significantly higher than the controls (p ‹ 0.05) (Table 1). The 
maximum value of VEGF expression was found at 16:00/30 in tumor-bearing mice, and at 
20:00/34 HD/HPH in the controls (Figure 1). In group II, not statistically significant differences 
were observed between the values of controls and treated animals (Table 2). The maximum 
values of VEGF expression were found at 16:00/30 in tumor-bearing mice, and at 08:00/46 
HD/HPH in the controls (Figure 2). As we can see in Table 3, statistically significant differences 
(p ‹ 0.05) in VEGF expression were observed between young and adult control mice, whereas 
in tumor-bearing mice not statistically differences were found (Table 4).
Discussion
Hepatic remodeling, followed by PH, involves a complex set of events including the activation 
and secretion of numerous growth factors, intense cell proliferation, and finally the restora-
tion of liver architecture. Angiogenesis is a fundamental part of this regenerative process to 
ensure the correct supply of blood for growing tissues. This process is stimulated by VEGF, 
the most important angiogenic growth factor (Fausto et al. 2006, 2012; Bockhorn et al. 2007; 
Aryal et al. 2016).
Different studies performed in rodents demonstrated circadian variations of VEGF expres-
sion in hepatocytes of regenerating livers following a partial hepatectomy in tumor and 
non-tumor-bearing adult mice, as well as in intact adult mice (Furnus et al. 2003; Andrini et 
al. 2011; Fernández Blanco et al. 2011). Taking this into consideration, we decided to compare 
VEGF expression in hepatocytes of young and adult hepatectomized and hepatectomized-tu-
mor-bearing mice. The results presented in this work show a circadian rhythm in VEGF expres-
sion of regenerating hepatocytes of young and adult mice. In the young hepatectomized 
no-bearing-tumor mice, the maximum expression value of VEGF in the circadian curve is at 
34 h post-surgery; while in the group of adult animals, the peak is observed 46 h post-hepa-
tectomy. These results coincide with other authors such as Kraizer et al. (2001) who showed 
Table 1. Daily mean values of VegF expression in hepatectomized (control) and hepatectomized and 
tumor-bearing young mice.
Notes: hD/hPh: hour of day/hours post-hepatectomy; X: mean; es: standard error; n: samples; p: probability; ns: not signif-
icant differences; tBm: tumor-bearing mice.
Lots HD/HPH Control (X ± SE) n TBM (X ± SE) n p
1 12:00/26 0.9 ± 0.6 8 1.9 ± 0.9 7 <0.05
2 16:00/30 1.1 ± 0.5 6 4.5 ± 1 6 <0.05
3 20:00/34 1.2 ± 0.5 7 1 ± 0.7 6 <0.05
4 00:00/38 0.1 ± 0.6 6 1.5 ± 0.5 6 <0.05
5 04:00/42 0.1 ± 0.6 6 1.5 ± 0.5 6 <0.05
6 08:00/46 0.6 ± 0.4 6 1.5 ± 0.5 6 <0.05
X 0.1 ± 0.1 5.2 ± 0.4 <0.05
p ns <0.05
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Table 2. Daily mean values of VegF expression in hepatectomized (control) and hepatectomized and 
tumor-bearing adult mice.
Notes: hD/hPh: hour of day/ hours post-hepatectomy; X: mean; es: standard error; n: samples; p: probability; ns: not signif-
icant differences; tBm: tumor-bearing mice.
Lots HD/HPH Control (X ± SE) n TBM (X ± SE) n p
1 12:00/26 1.8 ± 0.2 8 2.1 ± 0.1 7 ns
2 16:00/30 1.9 ± 0.2 6 3.7 ± 0.1 6 ns
3 20:00/34 1.7 ± 0.3 7 2.2 ± 0.2 6 ns
4 00:00/38 1.9 ± 0.3 6 1.2 ± 0.2 6 ns
5 04:00/42 2 ± 0.1 6 2.02 ± 0.2 6 ns
6 08:00/46 2.6 ± 0.1 6 1.8 ± 0.1 6 ns
X 1.9 ± 0.2 2.2 ± 0.1 ns
p <0.05 <0.001
Figure 1. comparison of VegF expression values in young hepatectomized (control) and hepatectomized 
tumor-bearing young mice along a circadian time span. each time point corresponds to the X ± es of 
VegF expression values given in table 1. the illuminating period regimen is indicated on the bottom line: 
light 06:00–18:00 h, dark 18:00–06:00 h.
Figure 2. comparison of VegF expression values in adult hepatectomized (control) and hepatectomized 
tumor-bearing adult mice along a circadian time span. each time point corresponds to the X ± es of VegF 
expression values given in table 2. the illuminating period regimen is indicated on the bottom line: light 
06:00–18:00 h, dark 18:00–06:00 h.
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an increase after hepatectomy in the expression of VEGF mRNA in hepatocytes between 24 
and 72 h after surgery.
As we can infer from the above-mentioned results, the maximum VEGF expression value 
in adult mice occurs 12 h after that of the young. This difference in the location of the VEGF 
expression peaks in the young and adult animals within the circadian curve could be due 
by the age of the animals. We suggest that adult animals may have a delayed angiogenesis 
because mature cells do not respond as quickly to as younger cells (Rivard et al. 1999; Sadoun 
and Reed 2003).
On the other hand, in the present work we demonstrated that the VEGF expression of 
the regenerating hepatocytes of mice bearing a subcutaneous tumor is expressed in a cir-
cadian manner in young and adult animals. However, these curves are different from those 
that of the control group, since the maximum VEGF expression values in tumor-bearing mice 
are advanced (to 30 and 34 h post-hepatectomy). It is possible that the advance in time of 
this angiogenic factor is required to form new blood vessels to supply nutrients and oxygen 
to growing liver. Maybe, tumor cells from hepatocellular carcinoma ES2 produce substances 
that are released into the general circulation and recognize the hepatocytes of regenerating 
liver, stimulating them to express VEGF (Errecalde et al. 2014). In relation to this, it is known 
that tumor growth, and its evolution, is a complex phenomenon controlled by an intricate 
pattern of competing processes (Pérez de Castro et al. 2007), in which a significant increase 
of growth factors is produces in plasma levels (Michalopoulos 2011). Some of these factors 
can “cross-talk” between the growing tumor and the regenerating liver (Andrini et al. 2010). 
It is possible that, within the host, the hepatocarcinoma directly or indirectly modifies VEGF 
expression of hepatocytes and thus contributes to maintain angiogenesis and its own growth 
(Tsuzuki et al. 2000).
Table 3. Daily mean values of VegF expression in hepatectomized (control) young and adult mice.
Notes: hD/hPh: hour of day/hours post-hepatectomy; X: mean; es: standard error; n: samples; p: probability; ns: not signif-
icant differences.
Lots HD/HPH Young (X ± ES) n Adult (X ± ES) n p
1 12:00/26 0.9 ± 0.6 8 1.8 ± 0.2 8 <0.05
2 16:00/30 1.1 ± 0.5 6 1.9 ± 0.2 6 <0.05
3 20:00/34 1.2 ± 0.5 7 1.7 ± 0.1 7 <0.05
4 00:00/38 0.1 ± 0.6 6 1.9 ± 0.3 6 <0.05
5 04:00/42 0.1 ± 0.6 6 2 ± 0.1 6 <0.05
6 08:00/46 0.6 ± 0.4 6 2.6 ± 0.1 6 <0.05
X 0.1 ± 0.1 2.3 ± 0.3 <0.05
p ns ns
Table 4. Daily mean values of VegF expression in hepatectomized-tumor-bearing young and adult mice.
Notes: hD/hPh: hour of day/ hours post-hepatectomy; X: mean; es: standard error; n: samples; p: probability; ns: not sig-
nificant differences.
Lots HD/HPH Young (X ± ES) n Adult (X ± ES) n p
1 12:00/26 1.9 ± 0.9 7 2.1 ± 0.1 7 ns
2 16:00/30 4.5 ± 1 6 3.7 ± 0.1 6 ns
3 20:00/34 1 ± 0.7 6 2.2 ± 0.2 6 ns
4 00:00/38 1.5 ± 0.5 6 1.2 ± 0.2 6 ns
5 04:00/42 1.5 ± 0.5 6 2.02 ± 0.2 6 ns
6 08:00/46 1.5 ± 0.5 6 1.8 ± 0.1 6 ns
X 5.2 ± 0.4 2.2 ± 0.8 ns
p <0.05 < 0.001
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The importance of the use of an animal model in these experiments is that the PH repro-
duces the surgery performed in patients to extirpate the primary hepatic tumor, whereas 
the grafted hepatocarcinoma would represent the hepatic metastasis. Besides, this model 
presents a close approach to the micro-environmental conditions, facilitating the interpre-
tation of the events that occur after an extirpation of primary hepatic tumor in patients. This 
could allow us to test different treatments in mice to be extrapolated to the patients.
Based on our results, we can affirm that the mice bearing a hepatocellular carcinoma 
presents modified VEGF expression patterns of hepatocytes in their intensity and temporality. 
Thus, the knowledge of the chronobiology of VEGF expression during hepatic regeneration 
after hepatectomy is of great importance to determine the right moment for the oncologic 
drug application, considering the age of the patient and the presence or absence of hepatic 
metastasis.
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